Paracrine Wnt signaling both promotes and inhibits human breast tumor growth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 17, 2013, Pages 6991-6996

  Green, Jennifer L ^a,b   La, Justin ^a   Yum, Kyu W ^a   Desai, Payal ^a   Rodewald, Luo Wei ^a   Zhang, Xiaomei ^c   Leblanc, Mathias ^a   Nusse, Roeland ^b   Lewis, Michael T ^c   Wahl, Geoffrey M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b STANFORD UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Luciferase; Tumor stroma; Wnt responsive reporter

Indexed keywords

CLAUDIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LENTIVIRUS VECTOR; WNT PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST CELL; BREAST TUMOR; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; ENRICHMENT CULTURE; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REPORTER GENE; SQUAMOUS CELL CARCINOMA; TRIPLE NEGATIVE BREAST CANCER; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; LUMINESCENT PROTEINS; MICE; MICE, SCID; PARACRINE COMMUNICATION; RECEPTOR, ERBB-2; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84876861153     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1303671110     Document Type: Article

References (38)

1. Clevers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149(6):1192-1205.
2. Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31(1): 99-109.
3. Ayyanan A, et al. (2006) Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci USA 103(10):3799-3804.
4. Incassati A, Chandramouli A, Eelkema R, Cowin P (2010) Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res 12(6):213.
5. Jönsson M, Borg A, Nilbert M, Andersson T (2000) Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer. Eur J Cancer 36(2):242-248.
6. Lin SY, et al. (2000) Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97(8): 4262-4266.
7. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330-337.
8. Howe LR, Brown AM (2004) Wnt signaling and breast cancer. Cancer Biol Ther 3(1): 36-41.
9. Klarmann GJ, Decker A, Farrar WL (2008) Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics 3(2):59-63.
10. van de Wetering M, et al. (2001) Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res 61(1):278-284.
11. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA (2004) An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6(5):497-506.
12. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11(3):R32.
13. DiMeo TA, et al. (2009) A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 69(13):5364-5373.
14. Chu J, et al. (2009) A novel far-red bimolecular fluorescence complementation system that allows for efficient visualization of protein interactions under physiological conditions. Biosens Bioelectron 25(1):234-239.
15. Biechele TL, Moon RT (2008) Assaying beta-catenin/TCF transcription with beta-cat-enin/TCF transcription-based reporter constructs. Methods Mol Biol 468:99-110.
16. Nervi B, et al. (2007) Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp Hematol 35(12):1823-1838.
17. Green JL, et al. (2013) Use of a molecular genetic platform technology to produce human Wnt proteins reveals distinct local and distal signaling abilities. PLoS ONE 8(3): e58395.
18. Perou CM, et al. (2000) Molecular portraits of human breast tumours. Nature 406(6797):747-752.
19. Sørlie T, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869-10874.
20. Herschkowitz JI, et al. (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8(5):R76.
21. Kao J, et al. (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 4(7): e6146.
22. Neve RM, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6):515-527.
23. Prat A, et al. (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12(5):R68.
24. Kuperwasser C, et al. (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101(14):4966-4971.
25. DeRose YS, et al. (2011) Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17(11):1514-1520.
26. Miettinen M (1993) Keratin immunohistochemistry: Update of applications and pitfalls. Pathol Annu 28(Pt 2):113-143.
27. Taube JH, et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107(35):15449-15454.
28. Wu ZQ, et al. (2012) Canonical Wnt signaling regulates Slug activity and links epi-thelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA 109(41):16654-16659.
29. Yook JI, et al. (2006) A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8(12):1398-1406.
30. Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE (2007) Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 9(5):R63.
31. Khalil S, Tan GA, Giri DD, Zhou XK, Howe LR (2012) Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: Relationship to HER2/neu expression in human and mouse. PLoS ONE 7(3):e33421.
32. Geyer FC, et al. (2011) beta-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod Pathol 24(2): 209-231.
33. Khramtsov AI, et al. (2010) Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 176(6):2911-2920.
34. Wu Y, et al. (2012) Expression of Wnt3 activates Wnt/beta-catenin pathway and promotes EMT-like phenotype in trastuzumab resistant HER2-overexpressing breast cancer cells. Mol Cancer Res 10(12):1597-1606.
35. Teulière J, et al. (2005) Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 132(2):267-277.
36. Miyoshi K, et al. (2002) Activation of beta-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci USA 99(1):219-224.
37. Kuraguchi M, Ohene-Baah NY, Sonkin D, Bronson RT, Kucherlapati R (2009) Genetic mechanisms in Apc-mediated mammary tumorigenesis. PLoS Genet 5(2):e1000367.
38. Marson A, et al. (2008) Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3(2):132-135.